Anything For You All
Found anything you want to know here
Advertisement
Kamis, 22 Oktober 2015
Credit Suisse is slashing a key trading business — and a lot of people are going to get fired
Pity the poor macro trader. Macro trading, which involves products such...
MANAGE SUBSCRIPTIONS
|
UNSUBSCRIBE
|
VIEW ONLINE
Finance
Select
October 22, 2015
Credit Suisse is slashing a key trading business — and a lot of people are going to get fired
Pity the poor macro trader. Macro trading, which involves products such...
Read»
Share this story:
From Ferrari to Facebook: the incredible client list of Wall Street's most secretive firm
Some of the biggest names in tech, telecom, and the media industries...
Read»
Share this story:
The fraud allegations against Valeant exposed an industry secret that's going to infuriate Washington
Whether you believe accounting fraud allegations levied against...
Read»
Share this story:
London: Rent is too damn high
It looks like London's runaway property market is finally having an...
Read»
Share this story:
The 10 most important things in the world right now
Good morning! Here's what you need to know on Thursday. 1. Mexico has...
Read»
This report proves that Britain is overwhelmingly anti-immigration and it could prompt Brexit
Britain gets to vote on whether it will stay in the European Union by...
Read»
I went to America's best taco joint — and it absolutely lived up to the hype
Before I visited Austin, Texas, my taco experience was limited...
Read»
Advertisement
EE has built a network for driverless cars
EE, Britain's biggest mobile network, is hoping a big chunk of its...
Read»
Share this story:
The refugee crisis slashed Eurotunnel's freight traffic by 33%
Europe is in the middle of the worst refugee crisis since World War II....
Read»
Share this story:
David Einhorn has gone back to one of his most famous short positions — and it's a killer call
Hedge fund manager David Einhorn, the founder of $8 billion Greenlight...
Read»
Share this story:
SHORT SELLER: Here's why pharmaceutical company Valeant looks like Enron
Valeant Pharmaceuticals is being accused of an Enron-like fraud...
Read»
Share this story:
See Also
Mark Carney just gave a massive boost to the 'In' campaign in Britain's EU referendum — whether he thinks it or not
Bank of England governor Mark Carney just waded into the long campaign...
Read»
The rise and fall of Valeant
Valeant Pharmaceuticals' share price went on a wild ride Wednesday. The...
Read»
Debenhams' CEO is throwing in the towel
The boss of struggling department store Debenhams is leaving after 5...
Read»
Controversial biotech CEO Martin Shkreli wants everyone to know he has bought Valeant shares
Former hedge fund manager and controversial biotech CEO Martin Shkreli...
Read»
Share:
Share:
Share:
Share:
Share this:
Email sent to:
|
Manage your email preferences
|
Unsubscribe
Terms of Service
|
Privacy Policy
Business Insider. 150 Fifth Avenue, New York, NY 10011
Tidak ada komentar:
Posting Komentar
Posting Lebih Baru
Posting Lama
Beranda
Langganan:
Posting Komentar (Atom)
Tidak ada komentar:
Posting Komentar